Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Virus specific peptide matrix design using previously defined HLA class I restricted CTL epitopes

From: Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Virus Optimal epitopes No. of peptide pools Max. no. of peptides per pools
HIV 173 29 14
EBV 91 23 12
CMV 38 13 7
HCV 77 19 11
HBV 37 14 8